Connect with us
Neuraxpharm aims for €500 million in net sales in 2024, up 13.6% from €440 million last year, driven by its focus on CNS disorder treatments. Acquisitions,...
Emerging technologies are pivotal in healthcare. GSK's María Cardenal-Iradier, Jorge Pou, and Sergio Ostalé presented to the IDIS Foundation's Innovation Committee their proposals using AI to...
LEO Pharma, specializing in medical dermatology and thrombosis, saw a 7% revenue increase in 2023, reaching €1.54 billion in net sales. In Spain, growth was 6.9%,...
Grifols increased its private bond issue by €300 million, totaling €1.3 billion. The bonds, maturing in May 2030 with a 7.5% annual coupon, will repay part...
The Biomechanics Institute (IBV) achieved 12.4 million euros in 2023, a 20% increase from the previous year, with 334 projects and 1,100 technological solutions developed for...
MicThera, a biotech startup from Lodi specializing in bacterial-inspired prostate cancer therapies, secured a €1 million investment from Indaco Bio Fund. The funds will develop new...
Tetra Pharm Technologies and Kvantify, both Copenhagen-based companies, are partnering to revolutionize drug discovery targeting the endocannabinoid system (ECS). This alliance aims to accelerate drug development,...
Oryzon Genomics shares rose nearly 3% after announcing its participation in the European Med4Cure project. Med4Cure, funded with €1 billion in public financing, aims to attract...
Vytrus Biotech raised €2.3 million through a capital round and share sales, led by Boyser and minority shareholders. The funds will support expansion and new technologies....
The leap to digitalization should serve the German group to boost its growth. Sources from B. Braun advance that the group had a turnover of 615...
 |
|
 |  |
 |
|